Clinical Characteristics and Mid-term Follow-up in Children with Isolated Complete Atrioventricular Block.
Journal
Anatolian journal of cardiology
ISSN: 2149-2271
Titre abrégé: Anatol J Cardiol
Pays: Turkey
ID NLM: 101652981
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
entrez:
7
2
2023
pubmed:
8
2
2023
medline:
9
2
2023
Statut:
ppublish
Résumé
Isolated complete atrioventricular block is a rare disease often associated with maternal autoantibodies. This study aimed to present the midterm data of patients at our clinic diagnosed with isolated complete atrioventricular block. We evaluated 108 patients diagnosed with isolated complete atrioventricular block. Demographic data of the patients, electrocardiography, echocardiography, 24-hour Holter monitoring data, and follow-up and complications of the patients who underwent pacemaker implantation were evaluated retrospectively. The mean age of the patients at diagnosis was 5.51 ± 5.05 years. At the time of diagnosis, 74.8% of the patients had no symptoms associated with complete atrioventricular block. The most common symptom was fatigue. Pacemaker implantation was needed in 88 (81.4%) patients during follow-up. Significant bradycardia was the most common pacemaker implantation indication. The mean battery life was 5.41 ± 2.65 years. The battery replacement-free period of 68 patients who underwent pacemaker implantation and continued their follow-up was 4.18 ± 2.89 (0.1-10) years. Pacemaker-related complications developed in 8 patients during follow-up. Left ventricular dysfunction developed (dyssynchrony induced) in 3 patients at follow-up, and all were paced from the right ventricular anterior wall. Those patients underwent cardiac resynchronization therapy and their left ventricular dysfunction improved. Isolated complete atrioventricular block is a rare disease requiring careful clinical follow-up. Patients are often asymptomatic and significant bradycardia is the most common indication for pacemaker implantation. Left ventricular dysfunction is an important cause of morbidity, especially in patients with right ventricular anterior wall pacing. Physicians should be aware of left ventricular dysfunction during follow-up. Cardiac resynchronization therapy should be considered as a treatment option for left ventricular dysfunction.
Sections du résumé
BACKGROUND
Isolated complete atrioventricular block is a rare disease often associated with maternal autoantibodies. This study aimed to present the midterm data of patients at our clinic diagnosed with isolated complete atrioventricular block.
METHODS
We evaluated 108 patients diagnosed with isolated complete atrioventricular block. Demographic data of the patients, electrocardiography, echocardiography, 24-hour Holter monitoring data, and follow-up and complications of the patients who underwent pacemaker implantation were evaluated retrospectively.
RESULTS
The mean age of the patients at diagnosis was 5.51 ± 5.05 years. At the time of diagnosis, 74.8% of the patients had no symptoms associated with complete atrioventricular block. The most common symptom was fatigue. Pacemaker implantation was needed in 88 (81.4%) patients during follow-up. Significant bradycardia was the most common pacemaker implantation indication. The mean battery life was 5.41 ± 2.65 years. The battery replacement-free period of 68 patients who underwent pacemaker implantation and continued their follow-up was 4.18 ± 2.89 (0.1-10) years. Pacemaker-related complications developed in 8 patients during follow-up. Left ventricular dysfunction developed (dyssynchrony induced) in 3 patients at follow-up, and all were paced from the right ventricular anterior wall. Those patients underwent cardiac resynchronization therapy and their left ventricular dysfunction improved.
CONCLUSION
Isolated complete atrioventricular block is a rare disease requiring careful clinical follow-up. Patients are often asymptomatic and significant bradycardia is the most common indication for pacemaker implantation. Left ventricular dysfunction is an important cause of morbidity, especially in patients with right ventricular anterior wall pacing. Physicians should be aware of left ventricular dysfunction during follow-up. Cardiac resynchronization therapy should be considered as a treatment option for left ventricular dysfunction.
Identifiants
pubmed: 36747457
doi: 10.14744/AnatolJCardiol.2022.2235
pmc: PMC9900412
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106-112Références
J Cardiovasc Electrophysiol. 2007 Apr;18(4):373-7
pubmed: 17394451
J Am Coll Cardiol. 2001 Mar 15;37(4):1129-34
pubmed: 11263619
Eur Heart J. 2012 Mar;33(5):622-9
pubmed: 21920962
Cardiovasc Ultrasound. 2007 Mar 12;5:13
pubmed: 17352821
Heart Rhythm. 2012 Oct;9(10):1737-53
pubmed: 22975672
Ann Thorac Surg. 2020 Jun;109(6):1913-1920
pubmed: 31715154
Pacing Clin Electrophysiol. 2016 Sep;39(9):935-43
pubmed: 27356498
Heart Rhythm. 2021 Nov;18(11):1888-1924
pubmed: 34363988
Pacing Clin Electrophysiol. 2002 Dec;25(12):1685-91
pubmed: 12520668
Pacing Clin Electrophysiol. 2001 Nov;24(11):1681-8
pubmed: 11816640
Heart Lung Circ. 2019 Jul;28(7):1127-1133
pubmed: 30064922
Heart Rhythm. 2022 Jul;19(7):1149-1155
pubmed: 35217197
Expert Rev Cardiovasc Ther. 2017 Nov;15(11):853-861
pubmed: 28875729
Pacing Clin Electrophysiol. 2020 Jun;43(6):535-541
pubmed: 32233121
Circ J. 2008 Jan;72(1):81-7
pubmed: 18159105
Europace. 2013 Aug;15(8):1070-118
pubmed: 23801827
Circulation. 2001 Mar 20;103(11):1599-604
pubmed: 11257091
J Clin Invest. 1994 Feb;93(2):718-24
pubmed: 8113406
Heart Rhythm. 2015 Nov;12(11):2278-84
pubmed: 26096611
Trends Cardiovasc Med. 2020 Jul;30(5):275-286
pubmed: 31262557
J Am Coll Cardiol. 2002 Jan 2;39(1):130-7
pubmed: 11755298